Skip to main content
. 2010 Feb 16;54(5):2201–2205. doi: 10.1128/AAC.01143-09

FIG. 1.

FIG. 1.

Time-kill curves for telavancin (TLV) and four comparator agents tested alone and in combination against a nosocomially acquired MRSA isolate (strain SA 1324). (A) TLV plus gentamicin (GEN). (B) TLV plus ceftriaxone (CRO). (C) TLV plus meropenem (MEM). (D) TLV plus rifampin (RIF).